• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,070.84 567.99
( 0.75%)
Global Indices
Nasdaq
46,970.79 391.31
(0.84%)
Dow Jones
6,721.52 68.33
(1.03%)
Hang Seng
53,528.27 -222.88
(-0.41%)
Nikkei 225
10,406.71 89.02
(0.86%)
Forex
USD-INR
92.32 0.03
(0.03%)
EUR-INR
105.40 -1.04
(-0.98%)
GBP-INR
122.05 -1.31
(-1.06%)
JPY-INR
0.58 0.00
(-0.37%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
369.1611632
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
34.66
74304.86
EPS(TTM)
Face Value()
Div & Yield %
36.91
1
0
 

As on: Mar 17, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,287.40 8.05 13913 34.66
Stock Price Details
Open Price() 1,299.75
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,299.75
Today's Low () 1,275.50
52-Week High () 1319.6
152-Week Low () 994.35
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 36.91
Book Value 369.1611632
Market Cap (.Cr) 74,304.86
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Aug
ISIN No. INE406A01037


News
Eugia Pharma Specialities launches Pomalidomide Capsules in US market
Aurobindo Pharma launches Pomalidomide capsules in US market
Aurobindo Pharma arm receives 4 observations after US FDA inspection
Eugia Pharma Specialities receives USFDA approval for Everolimus Tablets
Aurobindo Pharma gains as arm gets USFDA final nod for Everolimus tablets
Aurobindo Pharma Ltd spurts 1.16%
Aurobindo Pharma consolidated net profit rises 7.62% in the December 2025 quarter
Aurobindo Pharma board considers merger of subsidiaries
Board of Aurobindo Pharma approves PPA with Garuda Renewables
Aurobindo Pharma board appoints directors
More
Corporate Details
Incoporation Year   : 1986
Chairman : M R Kumar
Bussiness Group : Indian Private
Registered Office
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-23736370
Fax:91-40-23747340
Fax:91-22-66317458
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi